MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 25, 2006; DOI: 10.1124/mol.106.029793


0026-895X/07/7101-377-383$20.00
Mol Pharmacol 71:377-383, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.029793v1
71/1/377    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Vore, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Vore, M.

Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5' Untranslated Region

Yuanyuan Zhang, Wei Li, and Mary Vore

Graduate Center for Toxicology, Chandler Medical Center, University of Kentucky, Lexington, Kentucky

Multidrug resistance-associated protein 2 (Mrp2/Abcc2), an organic anion transporter present in the apical membrane of hepatocytes, renal epithelial cells, and enterocytes, is postulated to undergo translational regulation. Transcription of rat hepatic Mrp2 mRNA is initiated at multiple sites (-213, -163, -132, and -98 nucleotides relative to the Mrp2 ATG) and contains potential upstream open reading frames (uORFs) in the 5' untranslated region (UTR) starting at -213, -149 and -109 nucleotides. Ribonuclease protection assays demonstrated that transcription of the Mrp2 gene at the various initiation sites was tissue-specific, with the major initiation site in the liver and kidney being -98 and -132 nucleotides, respectively. In the jejunum, the primary and secondary initiation sites were -98 and -132 nucleotides, respectively, with the converse true in the ileum. The relative abundance of these Mrp2 transcripts expressed in tissues varied with age from birth to the adult. HepG2 transient expression assays and in vitro translation assays in which the 5'UTRs were fused with a luciferase reporter showed that the 5'UTR without any uORF (-98 nucleotide) expressed maximal luciferase activity compared with those with one (-132 nucleotides), two (-163 nucleotides), or three (-213 nucleotides) uORFs. Disruption of the uORF by site-directed mutagenesis at nucleotide -109 enhanced luciferase activity 2- to 3-fold, whereas disruption of the uORF at nucleotide -149 had little effect. We conclude that among the uORFs in the Mrp2 5'UTR, the uORF starting at nucleotide -109 probably plays an important role in the regulation of Mrp2 protein expression.


Received August 9, 2006; accepted October 25, 2006

Address correspondence to: Dr. Mary Vore, Graduate Center for Toxicology, HSRB306, University of Kentucky, Lexington, KY 40536-0305. E-mail: maryv{at}uky.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics